NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

Institutional clients can use cUSDO, OpenEden Digital’s yield-bearing digital asset, as collateral on MirrorRSV while ...

A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Each year, almost 200,000 adults 65 and older are hospitalized due to RSV, and an estimated 14,000 of those cases result in ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be ...

Researchers at MIT and other institutions have identified compounds that can fight off viral infection by activating a ...

The flu, COVID-19, and RSV are distinct respiratory illnesses caused by different viruses, but they often present with overlapping symptoms, making it challenging to differentiate between them ...